메뉴 건너뛰기




Volumn 35, Issue 2, 2002, Pages 197-200

Concomitant risk factors in reports of torsades de pointes associated with macrolide use: Review of the united states food and drug administration adverse event reporting system

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CISAPRIDE; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; MACROLIDE;

EID: 0037100316     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/340861     Document Type: Article
Times cited : (128)

References (12)
  • 2
    • 0034244378 scopus 로고    scopus 로고
    • The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: Clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology
    • (2000) Eur Heart J , vol.21 , pp. 1216-1231
    • Haverkamp, H.1    Brelthardt, G.2    Camm, A.J.3
  • 3
    • 0034728805 scopus 로고    scopus 로고
    • Risk of torsades de pointes with non-cardiac drugs: Doctors need to be aware that many drugs can cause QT prolongation
    • (2000) BMJ , vol.320 , pp. 1158-1159
    • Yap, Y.1    Camm, J.2
  • 4
    • 0035293881 scopus 로고    scopus 로고
    • Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes
    • (2001) Pharmacotherapy , vol.21 , pp. 301-319
    • Owens R.C., Jr.1
  • 8
    • 0027252647 scopus 로고
    • Introducing MedWatch: A new approach to reporting medication and device adverse effects and product problems
    • (1993) JAMA , vol.269 , pp. 2765-2768
    • Kessler, D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.